Of all the cases of economic espionage charged by the DOJ's National Security Division since 2012, more than 80% of them implicated China.World Politicsread more
"Whilst there is a big dispute at the moment, I think there's also potential for resolution," UBS chairman Axel Weber says of the U.S.-China trade negotiations.World Economyread more
Cryptocurrency fans will hope the futures contracts, which are federally regulated, can provide some much-needed legitimacy to bitcoin.Cryptocurrencyread more
Despite mixed fan and critic reactions to the final season of "Game of Thrones," the eight-season epic took home the top prize in the drama category at the Emmy Awards on...Entertainmentread more
There are alternative financial centers and investors can turn to Singapore, Tokyo or Shanghai if Hong Kong doesn't "shape up," says the founder and chairman of Citic Capital.Asia Economyread more
The Kingdom and oil and gas industry have been slow to shore up defenses, raising red flags about the possibility of longer term fall-out in the region.Technologyread more
Tensions between South Korea and Japan may ultimately disrupt the high-end tech sectors, says Heenam Choi, CEO at South Korea's sovereign wealth fund.Traderead more
On Sunday, the 71st Primetime Emmy Awards honored the best comedies, dramas, limited and variety series from the last year.Entertainmentread more
U.S. President Donald Trump's national security advisor said on Sunday that White House Asia policy adviser Matt Pottinger would become his top deputy.Politicsread more
Removing Neumann is a difficult decision for Son, who has long believed in WeWork and Neumann's vision to quickly expand the company.Technologyread more
Datadog went public on Thursday and instantly hit a $10 billion valuation, becoming the fourth cloud software debut to reach that level this year.Technologyread more
U.S. spending on health care is nearly twice the rate of 10 other high-income countries, according to a study in the Journal of the American Medical Association.
Americans used health care at similar rates as their peers, the researchers said in the study published Tuesday. Labor, administrative and drug costs helped drive the differences in spending.
Health-care spending ballooned to nearly 18 percent of the U.S. gross domestic product in 2016. That figure ranges from about 10 percent to 12 percent in the 10 other nations — the United Kingdom, Canada, Germany, Australia, Japan, Sweden, France, the Netherlands, Switzerland and Denmark, according to the paper.
The U.S. had the highest pharmaceutical spending per capita among its peers at $1,443, the researchers found, compared with an average of $749 for all 11 countries. Generics represented 84 percent of the U.S. market, the highest amount among peers.
"Despite having the highest rate of generic penetration, the amount that the United States spent on generic products as a percentage of total pharmaceutical spending was similar to other countries, suggesting that brand-name pharmaceuticals were largely responsible for high overall spending," the researchers wrote.
The Harvard-based researchers were led by Irene Papanicolas, a visiting professor at Harvard from the London School of Economics and Politics.
How drugs are paid for varies among the countries studied. A recent White House report recommended finding a way to get foreign nations to "price drugs at levels that appropriately reward innovation, rather than disproportionately putting that that burden on American patients and taxpayers."
The U.S. had high levels of administrative burden, the researchers found. In the country, 8 percent of GDP was spent on administration and governance compared with the average of 3 percent of GDP.
Labor costs also contributed to the spending disparity. Salaries for generalists, specialists and nurses were all higher in the U.S. than in the other countries.
And while the U.S. spent the most on health care, it performed the worst on some measures. Life expectancy of 78.8 years was lower than the average of 81.7 years among the countries studied. Infant mortality was the highest, at 5.8 deaths per 1,000 live births in the U.S., compared with the average of 3.6 per 1,000.
The report comes as calls for a better system have grown. President Donald Trump has repeatedly accused drugmakers of "getting away with murder." Technology giants have entered the space promising to do better. Even Amazon's Jeff Bezos, J.P. Morgan's Jamie Dimon and Berkshire Hathaway's Warren Buffett have partnered to try to lower costs.
The researchers said data such as these "are needed to inform policy decisions" as patients, physicians, policymakers and legislators debate the future of the U.S. health system.